Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Krystal Biotech, Inc.    KRYS

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
11/04/2019 | 08:03am EDT

Item 7.01 Regulation FD Disclosure.

On November 4, 2019, Krystal Biotech, Inc., a Delaware corporation (the "Company"), announced its third quarter fiscal year 2019 financial results. A copy of the Company's press release is attached as Exhibit 99.1 hereto and incorporated by reference herein.

The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be incorporated into any registration statement or other document filed with the Securities and Exchange Commission by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.



               Exhibit
                 No.     Description

               99.1        Press Release, dated November 4, 2019.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on KRYSTAL BIOTECH, INC.
03/10KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
03/10KRYSTAL BIOTECH : Management's Discussion and Analysis of Financial Condition an..
AQ
03/10Krystal Biotech Reports 2019 Financial Results and Business Progress
GL
02/25KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Financial Sta..
AQ
02/25Krystal Biotech Announces Change in Financial Leadership
GL
02/21Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
GL
01/24KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Breaks Ground On Second Commerci..
PU
01/24Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing..
GL
01/21Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
GL
2019Pfizer, Novartis lead $2 billion spending spree on gene therapy production
RE
More news